{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:08:07Z","timestamp":1791504487692,"version":"4.3.4"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      High-grade cervical intraepithelial neoplasia (CIN) is a precancerous lesion of cervical cancer. The aims of this study were to evaluate the risk factors for recurrence of high-grade CIN and to determine if the specific genotype of human papillomavirus (HPV) is a predictor of recurrent high-grade CIN. Between January 2010 and December 2014, 172 patients with CIN 2+ underwent cold knife conization or a loop electrosurgical excision. The HPV DNA chip was used to detect HPV. Recurrent lesions were histologically confirmed and considered to be recurrence of CIN2+. We compared the recurrence rate in patients who did and did not have HPV infection after treatment. One hundred forty-eight (86%) patients had HPV infection before treatment. The first follow-up HPV test was performed on average 4.6 months after treatment and the recurrence rate for high-grade CIN was 3.5%. Fifty-eight patients (33.7%) were found to have HPV infection after treatment; of these, 14 (24.1%) had HPV genotype 16 and\/or 18. Eleven patients had persistent HPV16 and\/or 18 infection and 3 had new HPV 16 infection after treatment (78.6% and 21.4%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a.001); the HPV 16 genotype was significantly correlated with recurrent disease and persistent infection after treatment (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a.013 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a.054, respectively, [OR], 19.4; 95% [CI], 1.89\u2013198.79). Recurrence of high-grade CIN was related to HPV infection after treatment, and persistent HPV16 infection was the most important factor for recurrence. Therefore, HPV vaccination for the HPV16 genotype and regular follow-up with HPV testing after treatment may be useful for preventing recurrent high-grade CIN.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000013606","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T22:16:34Z","timestamp":1545257794000},"page":"e13606","source":"Crossref","is-referenced-by-count":51,"title":["Persistent HPV-16 infection leads to recurrence of high-grade cervical intraepithelial neoplasia"],"prefix":"10.1097","volume":"97","author":[{"given":"Jung Mi","family":"Byun","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology"},{"name":"Paik Institute for Clinical Research, Busan Paik Hospital, Inje University, Busan, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Hoon","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology"},{"name":"Paik Institute for Clinical Research, Busan Paik Hospital, Inje University, Busan, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Nam","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology"},{"name":"Paik Institute for Clinical Research, Busan Paik Hospital, Inje University, Busan, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jung","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Bok","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology"},{"name":"Paik Institute for Clinical Research, Busan Paik Hospital, Inje University, Busan, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Su","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology"},{"name":"Paik Institute for Clinical Research, Busan Paik Hospital, Inje University, Busan, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Tae","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology"},{"name":"Paik Institute for Clinical Research, Busan Paik Hospital, Inje University, Busan, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00003081-200006000-00015","article-title":"Natural history of cervical neoplasia: defining progression and its consequence","volume":"43","author":"Pinto","year":"2000","journal-title":"Clin Obstet Gynecol"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajog.2004.01.043","article-title":"Diagnoses and outcomes in cervical cancer screening: a population-based study","volume":"191","author":"Insinga","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"issue":"(5 Part 1)","key":"R4-20230914","first-page":"965","article-title":"Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia","volume":"100","author":"Elfgren","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","article-title":"Natural history of cervical intraepithelial neoplasia: a critical review","volume":"12","author":"\u00d6st\u00f6r","year":"1993","journal-title":"Int J Gynecol Pathol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bpobgyn.2011.04.005","article-title":"Histology of cervical intraepithelial neoplasia and the role of biomarkers","volume":"25","author":"Martin","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1067\/mob.2003.633","article-title":"2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia","volume":"189","author":"Wright","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1470-2045(07)70283-8","article-title":"Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis","volume":"8","author":"Ghaem-Maghami","year":"2007","journal-title":"Lancet Oncol"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/01.AOG.0000206777.28541.fc","article-title":"Prediction of persistence or recurrence after conization for cervical intraepithelial neoplasia III","volume":"107","author":"Lu","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejogrb.2012.06.026","article-title":"Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study","volume":"165","author":"Serati","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/ijc.21604","article-title":"Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia","volume":"118","author":"Soutter","year":"2006","journal-title":"Int J Cancer"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5468\/ogs.2014.57.1.37","article-title":"Effect of human papillomavirus genotype on severity and prognosis of cervical intraepithelial neoplasia","volume":"57","author":"Ku","year":"2014","journal-title":"Obstet Gynecol Sci"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/gyno.2000.5952","article-title":"Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?","volume":"79","author":"Nagai","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejogrb.2004.06.029","article-title":"Role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical precancerous lesions","volume":"118","author":"Hern\u00e1di","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1056\/NEJMct0806938","article-title":"HPV vaccination for the prevention of cervical intraepithelial neoplasia","volume":"361","author":"Kahn","year":"2009","journal-title":"N Engl J Med"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ijc.26349","article-title":"Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment","volume":"131","author":"Kreimer","year":"2012","journal-title":"Int J Cancer"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2013.04.050","article-title":"Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)?","volume":"130","author":"Kang","year":"2013","journal-title":"Gynecol Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201812210-00048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T16:53:43Z","timestamp":1694710423000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201812210-00048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":19,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000013606","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}